abstract |
The present invention relates to a bispecific antigen binding molecule, comprising a first antigen-binding domain specifically binding to ANG-2, and a second antigen-binding domain specifically binding to VEGF. At the same time, the present invention also relates to a monoclonal antibody specifically binding to ANG-2, the preparation of the antibody and an application thereof. |